Joseph F. Goldberg, MD

JCP
Consensus Statement

January 28, 2020

Tardive dyskinesia remains a serious complication associated with dopamine receptor blocking agents. In this article, read guidance from experts on best practices for tardive dyskinesia screening, diagnosis, and treatment.
, , , et al
JCP
Commentary

December 3, 2019

This commentary discusses the findings and implications of a recent post hoc study by Thase and colleagues on the utility of combinatorial pharmacogenomics in depression.
JCP
Educational Activity

July 30, 2019

New mechanisms of action present new opportunities to improve outcomes for patients with depression. Listen to a panel of experts discuss best practices and novel antidepressants at the 2019...
, , , et al
JCP
The Differential Diagnosis of MDD Versus BP
Academic Highlights

May 14, 2019

Given the similarity in clinical presentation between major depressive disorder (MDD) and the depressive episodes of bipolar disorder (BP), misdiagnoses occur too often. Read this Academic Highlights to learn...
, , , et al
JCP
ASCP Corner

October 30, 2018

Both undertreatment and futile overtreatment can be disastrous. How can clinicians find the right balance? This ASCP Corner article discusses related ethical and practical issues and then delineates the...
JCP
ASCP Corner

August 8, 2017

The potential for pharmacogenetic testing to help guide treatment is currently a hot topic within Psychiatry. In this ASCP Corner article, Joseph F. Goldberg considers whether the technology has...
JCP
Case Report

December 23, 2015

, , , et al
JCP
Commentary

March 25, 2015

JCP
Consensus Statement

March 25, 2015

, , , et al
JCP
Commentary

July 25, 2014

JCP
ASCP Corner

February 15, 2013

,
JCP
Article

December 15, 2012

, ,

Celebrating
85 Years

Read the Journal of Clinical Psychiatry

Subscribe to read
more articles

Subscribe